Case Comprehensive Cancer Center

Case CCC Molecular Oncology Program member Khalid Sossey-Alaoui, PhD, and Thomas Jefferson University's Lucia Languino, PhD, conducted a collaborative study that appears in a recent Journal of Extracellular Vesicles. The study, Expression of the αVβ3 integrin affects prostate cancer sEV cargo and de...

Daniel Spratt, MD, member of Case CCC's Developmental Therapeutics Program, conducted a retrospective cohort study assessing the associations between the Decipher Genomic Classifier (Decipher GC), a test that improves understanding of the aggressiveness of a patient's prostate cancer, and risks of m...

Case Comprehensive Cancer Center (Case CCC) and Cleveland Metroparks have partnered to make it easier for people to prevent skin cancer. Free sunscreen will be available to all visitors at participating Cleveland Metroparks beaches and golf courses. The project, “Be Sun Smart. Protect Your Skin wi...

Case CCC Population and Cancer Prevention Program member, Mohamed Draz, PhD, provided background information for a study published this week in MDLinx that indicates honey bees can detect certain cancers with nearly 90% accuracy. Draz explains, “Cancer metabolism produces specific compounds that ar...

A study with Case CCC's Population and Cancer Prevention Co-Leader Stephanie Schmit, PhD, MPH, as Principal Investigator aims to close the healthcare gap that disproportionately affects Hispanic/Latino (H/L) communities in the U.S. by identifying colorectal cancer screening (CRC) screening hotspots,...

Case Comprehensive Cancer Center (Case CCC) and Cleveland Metroparks have partnered to make it easier for people to prevent skin cancer. Free sunscreen will be available to all visitors at participating Cleveland Metroparks beaches and golf courses. The project, "Be Sun Smart. Protect Your Skin wi...

The evolution of resistance to diseases, from infectious illnesses to cancers, poses a formidable challenge. Despite the expectation that resistance-conferring mutations would dwindle in the absence of treatment due to a reduced growth rate, preexisting resistance is pervasive across diseases that ...

Reda Riffi, a first-generation student at Case Western Reserve University, was selected to participate in the BioMed Amgen Scholars Program at Yale University this summer. Riffi is majoring in neuroscience and conducts research at CWRU in the Xiong Lab. The BioMed Amgen Scholars Program is a highly...

With a new five-year, $2.78 million grant from the National Institutes of Health and National Cancer Institute, researchers at Case Western Reserve University (CWRU), Cleveland Clinic and University Hospitals (UH) will use artificial intelligence (AI) to better treat rectal cancer patients. The Ame...

Nathan Berger with his wife, Sosamma J. Berger Nathan Berger arrived in Cleveland in 1983 with a vision: creating an oncology/hematology training program to position Case Western Reserve University School of Medicine as a leader in the burgeoning field of cancer care. The program he developed wen...